Poop pills join the fight against advanced colon cancer
NCT ID NCT07509398
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding fecal microbiota transplantation (FMT) – transferring gut bacteria from a healthy donor – to standard chemotherapy can shrink tumors in people with advanced colorectal cancer that cannot be removed by surgery. About 220 adults will be randomly assigned to receive either standard therapy alone or standard therapy plus FMT. The main goal is to see if the combination leads to more tumor shrinkage and possibly makes the cancer operable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (LOCALLY ADVANCED OR METASTATIC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart missile drug takes aim at Hard-to-Treat colorectal cancer
- Engineered immune cells take aim at Hard-to-Treat colorectal cancer
- Triple therapy aims to turn inoperable bowel cancer into surgical candidates
- New scan could reveal hidden cancer spread
- Engineered donor cells take aim at Hard-to-Treat cancers
- New chemo delivery method aims to shrink untreatable colon tumors